On combining data from genome-wide association studies to discover disease-associated SNPs

From MaRDI portal
Publication:908136

DOI10.1214/09-STS286zbMATH Open1329.62434arXiv1010.5046OpenAlexW2092706317MaRDI QIDQ908136FDOQ908136


Authors: Ruth M. Pfeiffer, Mitchell H. Gail, David Pee Edit this on Wikidata


Publication date: 3 February 2016

Published in: Statistical Science (Search for Journal in Brave)

Abstract: Combining data from several case-control genome-wide association (GWA) studies can yield greater efficiency for detecting associations of disease with single nucleotide polymorphisms (SNPs) than separate analyses of the component studies. We compared several procedures to combine GWA study data both in terms of the power to detect a disease-associated SNP while controlling the genome-wide significance level, and in terms of the detection probability (mathitDP). The mathitDP is the probability that a particular disease-associated SNP will be among the T most promising SNPs selected on the basis of low p-values. We studied both fixed effects and random effects models in which associations varied across studies. In settings of practical relevance, meta-analytic approaches that focus on a single degree of freedom had higher power and mathitDP than global tests such as summing chi-square test-statistics across studies, Fisher's combination of p-values, and forming a combined list of the best SNPs from within each study.


Full work available at URL: https://arxiv.org/abs/1010.5046




Recommendations




Cites Work


Cited In (14)





This page was built for publication: On combining data from genome-wide association studies to discover disease-associated SNPs

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q908136)